CD8+ T-cell responses against hemoglobin-β prevent solid tumor growth

Cancer Research

Volumn 68, Issue 19, 2008, Pages 8076-8084

  Komita, Hideo ^a   Zhao, Xi ^a   Taylor, Jennifer L ^a   Sparvero, Louis J ^a,b   Amoscato, Andrew A ^a,b   Alber, Sean ^a   Watkins, Simon C ^a   Pardee, Angela D ^a   Wesa, Amy K ^a   Storkus, Walter J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DENDRITIC CELL VACCINE; HEMOGLOBIN BETA CHAIN; MESSENGER RNA; RECOMBINANT INTERLEUKIN 12; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; SOLID TUMOR; TUMOR GROWTH; VIRUS RECOMBINANT;

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HEMOGLOBINS; IMMUNITY, CELLULAR; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED BALB C; NEOPLASMS; PEPTIDE FRAGMENTS; TRANSPLANTATION, ISOGENEIC; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 54249158378     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0387     Document Type: Article

References (37)

1. Tatsumi T, Huang J, Gooding WE, et al. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity. Cancer Res 2003;63:6378-86.
2. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005;7:452-64.
3. Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med 2006;10:857-65.
4. von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006;312:623-9.
5. Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002;51:3107-12.
6. Braun A, Xu H, Hu F, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci 2007;27:12012-24.
7. Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 2005;15:102-11.
8. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-β-deficient mice. Science 1997;277:242-5.
9. Kaplan CD, Krüger JA, Zhou H, Luo Y, Xiang R, Reisfeld RA. A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine 2006;24:6994-7002.
10. Storkus WJ, Zeh HJ III, Maeurer MJ, Salter RD, Lotze MT. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol 1993;151:3719-27.
11. + T lymphocytes from human blood. Proc Natl Acad Sci U S A 1999;96:12033-8.
12. Ochoa-Garay J, McKinney DM, Kochounian HH, McMillan M. The ability of peptides to induce cytotoxic T cells in vitro does not strongly correlate with their affinity for the H-2Ld molecule: implications for vaccine design and immunotherapy. Mol Immunol 1997;34:273-81.
13. + T cell cross-priming, but is ineffective as a therapy. Cancer Res 2006;66:4895-903.
14. Kahn SE, Watkins BF, Bernes EW, Jr. An evaluation of a spectrophotometric scanning technique for the rapid determination of plasma hemoglobin. Ann Clin Lab Sci 1981;11:126-31.
15. Borda JT, Alvarez X, Mohan M, et al. CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am J Pathol 2008;172:725-37.
16. + T-cell epitope derived from γ-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia. Blood 2006;108:2662-8.
17. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005;33:259-71.
18. Liu L, Zeng M, Stamler JS. Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci U S A 1999;96:6643-7.
19. Bhaskaran M, Chen H, Chen Z, Liu L. Hemoglobin is expressed in alveolar epithelial type II cells. Biochem Biophys Res Commun 2005;333:1348-52.
20. Gorr TA, Cahn JD, Yamagata H, Bunn HF. Hypoxia-induced synthesis of hemoglobin in the crustacean Daphnia magna is hypoxia-inducible factor-dependent. J Biol Chem 2004;279:36038-47.
21. Bichet S, Wenger RH, Camenisch G, et al. Oxygen tension modulates β-globin switching in embryoid bodies. FASEB J 1999;13:285-95.
22. Dewever J, Frérart F, Bouzin C, et al. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am J Pathol 2007;171:1619-28.
23. Lin M, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis and growth. Cancer Res 2007;67:2849-56.
24. Faivre-Fiorina B, Caron A, Fassot C, et al. Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. Am J Physiol 1999;276:H766-70.
25. Moestrup SK, Møller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the antiinflammatory response. Ann Med 2004;36:347-54.
26. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005;210:153-60.
27. Kruckeberg WC, Doorenbos DI, Brown PO. Genetic differences in hemoglobin influence on erythrocyte oxidative stress hemolysis. Blood 1987;70:909-14.
28. Poole RK, Hughes MN. New functions for the ancient globin family: bacterial responses to nitric oxide and nitrosative stress. Mol Microbiol 2000;36:775-83.
29. Gladwin MT, Ognibene FP, Pannell LK, et al. Relative role of heme nitrosylation and β-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A 2000;97:9943-8.
30. Roesch-Ely M, Nees M, Karsai S, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007;26:54-64.
31. Ramage JM, Metheringham R, Conn A, et al. Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. Int J Cancer 2004;110:245-50.
32. + T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth. J Immunother 2006;29:32-40.
33. Wada S, Tsunoda T, Baba T, et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 2005;65:4939-46.
34. Ishizaki H, Tsunoda T, Wada S, Yamauchi M, Shibuya M, Tahara H. Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1. Clin Cancer Res 2006;12:5841-9.
35. Lu C, Kamat AA, Lin YG, et al. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 2007;13:4208-17.
36. Evel-Kabler K, Song XT, Aldrich M, Huang XF, Chen SY. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest 2006;116:90-100.
37. Belladonna ML, Grohmann U, Bianchi R, et al. The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. J Chemother 1998;10:157-9.